Daily non-political popular news in brief.

Advanced cancer patients prone to poor sleep quality, daytime sleepiness, Emory study shows

Patients with advanced-stage cancer experience very poor sleep quality and often have troubling staying awake, says Emory University researcher Kathy Parker, PhD, RN.

Read more »

Keywords: advanced, cancer, patients, prone, poor, sleep, quality, daytime, sleepiness, emory, study, shows, patient, show

« Previous | Next »

Similar news on "Advanced cancer patients prone to poor sleep quality, daytime sleepiness, Emory study shows":

1. Personalized diets may offer relief to advanced cancer patients
   03-09-2007 · EurekAlert!
   Researchers at the University of Alberta studying the effects of chemotherapy and radiation therapy on the senses report that most advanced cancer patients experience unique and persistent taste and smell abnormalities, believed to be a key factor in malnutrition and poor quality of life. Their study suggests that every patient with chemosensory dysfunction has unique symptoms, and a diet tailored to his/her needs would likely improve quality of life.
   Similar news · Read more »
   
2. Journal Sleep: Advanced cancer patients have less quality sleep
   06-01-2007 · EurekAlert!
   Patients with stage four cancer are more prone to disturbed sleeping patterns due to factors such as pain, treatment side effects and psychological causes, according to a study published in the June 1 issue of the journal Sleep.
   Similar news · Read more »
   
3. Novel MS drug shows promise in 2 lethal leukemias
   08-28-2007 · EurekAlert!
   A new study suggests that an experimental drug being tested for the treatment of multiple sclerosis and to prevent organ rejection might also help people with certain deadly forms of chronic and acute leukemia. The laboratory and animal study focused on the drug, called fingolimod. Researchers said it might help patients with advanced chronic myelogenous leukemia or acute lymphocytic leukemia, and whose cancer cells show a particular genetic change called the Philadelphia chromosome.
   Similar news · Read more »
   
4. OHSU Cancer Institute shows findings of immunotherapy vaccine in prostate cancer patients
   06-02-2007 · EurekAlert!
   The study showed that sipuleucel-T did not significantly delay the time it took for a patient's PSA to reach a value of 3 ng/ml, the primary endpoint of the study, but it did show a prolongation in prostate-specific antigen doubling time (PSADT).
   Similar news · Read more »
   
5. Research shows survival benefit for leukemia patients treated with arsenic trioxide
   06-04-2007 · EurekAlert!
   Through participation in a government-sponsored multi-year study, researchers at the Comprehensive Cancer Center at Wake Forest University have helped confirm that arsenic trioxide -- marketed as Trisenox -- significantly improves patient survival when coupled with standard chemotherapy treatment in newly diagnosed patients with acute promyelocytic leukemia, or APL.
   Similar news · Read more »
   
6. What's going on in the body? Advanced time-of-flight PET takes a superior 'look'
   06-04-2007 · EurekAlert!
   Moving from computer simulation to patient images, researchers are now demonstrating the benefits that time-of-flight/PET imaging can provide for cancer patients. The result? Superior images and shorter patient scan times for starters, according to a study released at the 54th Annual Meeting of SNM, the world's largest society for molecular imaging and nuclear medicine professionals, June 2-6 in Washington, D.C.
   Similar news · Read more »
   
7. Experimental drug shows promise in advanced kidney cancer
   09-26-2007 · EurekAlert!
   A new drug has shown promise in patients with advanced kidney cancer whose options run out after their tumor fails to respond to the cutting edge therapy. The study, presented today at the European Cancer Conference in Barcelona, showed that the experimental drug, axitinib, shrank tumors and delayed progression of the disease in a group of patients who are among the toughest to treat.
   Similar news · Read more »
   
8. Patient navigators help minority, low-income cancer patients get life-saving treatments
   10-28-2007 · EurekAlert!
   Volunteers who guide low-income and minority cancer patients through cancer treatment, called lay patient navigators, help them to overcome major obstacles that prevent them from receiving quality care and achieving better outcomes, according to a study presented Oct. 28, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.
   Similar news · Read more »
   
9. Family counseling improves lives of patients and spouses coping with prostate cancer
   11-12-2007 · EurekAlert!
   Families coping with prostate cancer report improved quality of life from a structured support program integrated into the patient's cancer management, according to a new study.
   Similar news · Read more »
   
10. Quality of life: most important predictor of survival for advanced NSCLC patients
    10-30-2007 · EurekAlert!
    Healthcare providers have observed it for years -- patients who appear to have a better quality of life while battling their cancer live longer. Now, a prospective, multi-institutional study examining the quality of life of patients with locally advanced non-small cell lung backs that observation. In fact, quality of life is so important, it outweighs other classic predictors of survival.
    Similar news · Read more »